Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin